Insider Transactions in Q3 2021 at Aclaris Therapeutics, Inc. (ACRS)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 01
2021
|
Joseph Monahan Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,041
-1.19%
|
$17,697
$17.22 P/Share
|
|
Sep 01
2021
|
Joseph Monahan Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,333
+2.59%
|
-
|
|
Jul 13
2021
|
David N. Gordon Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,631
-1.75%
|
$42,096
$16.98 P/Share
|
|
Jul 02
2021
|
David N. Gordon Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+3.84%
|
-
|